NCT07368478 2026-01-26
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Patients With Advanced Solid Malignancies
Biocity Biopharmaceutics Co., Ltd.
Phase 1 Recruiting
Biocity Biopharmaceutics Co., Ltd.
BioRay Pharmaceutical Co., Ltd.